Biologic response modifiers for ophthalmologists.
Garrity
James A
JA
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA. garrity.james@mayo.edu
Matteson
Eric L
EL
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003607:Dacryocystitis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy; D000069285:Infliximab; D009885:Ophthalmology; D016727:Orbital Pseudotumor / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000069285:Infliximab